Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
85.6M
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
14.5M
-
Shares change
-
-24.7K
-
Total reported value, excl. options
-
$167M
-
Value change
-
+$200K
-
Number of buys
-
28
-
Number of sells
-
-13
-
Price
-
$11.53
Significant Holders of Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share (LRMR) as of Q3 2021
55 filings reported holding LRMR - Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q3 2021.
Larimar Therapeutics, Inc. - Common Stock, par value $0.001 per share (LRMR) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.5M shares
of 85.6M outstanding shares and own 16.95% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (5.83M shares), RA CAPITAL MANAGEMENT, L.P. (1.52M shares), CHI Advisors LLC (1.52M shares), Opaleye Management Inc. (833K shares), JANUS HENDERSON GROUP PLC (641K shares), VANGUARD GROUP INC (410K shares), Vivo Capital, LLC (400K shares), CITADEL ADVISORS LLC (309K shares), Atlas Venture Advisors, Inc. (292K shares), and 683 Capital Management, LLC (257K shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.